Lennox-Gastaut Syndrome (LGS)
Symptoms, Doctors, Treatments, Advances & More

Save information for later
Sign Up

Learn About Lennox-Gastaut Syndrome (LGS)

What is the definition of Lennox-Gastaut Syndrome (LGS)?

Lennox-Gastaut syndrome is a severe condition characterized by repeated seizures (epilepsy) that begin early in life. Affected individuals have multiple types of seizures, developmental delays, and particular patterns of brain activity measured by a test called an electroencephalogram (EEG). An EEG shows a slow spike-and-wave pattern during wakefulness and generalized paroxysmal fast activity during sleep.

What are the causes of Lennox-Gastaut Syndrome (LGS)?

Lennox-Gastaut syndrome can have many different causes. The disorder likely has a genetic component, although the specific genetic factors are not well understood.

How prevalent is Lennox-Gastaut Syndrome (LGS)?

Lennox-Gastaut syndrome affects an estimated 1 to 2 per million people worldwide. This condition accounts for 3 to 4 percent of cases of epilepsy in children and 1 to 2 percent of cases in adults. For unknown reasons, it appears to be more common in males than in females.

Is Lennox-Gastaut Syndrome (LGS) an inherited disorder?

Most cases of Lennox-Gastaut syndrome are sporadic, which means they occur in people with no history of the disorder in their family. When Lennox-Gastaut syndrome is associated with a genetic change, the variant is usually not inherited but occurs as a random (de novo) event during the formation of reproductive cells (eggs or sperm) in an affected person's parent or during early embryonic development. However, 3 to 30 percent of people with this condition have a family history of some type of epilepsy, indicating that inherited genetic factors may play a role in some cases of Lennox-Gastaut syndrome.

Who are the top Lennox-Gastaut Syndrome (LGS) Local Doctors?
Elite in Lennox-Gastaut Syndrome (LGS)
Elite in Lennox-Gastaut Syndrome (LGS)
Referral may be required

Werner K Doyle M.D. PC

223 E 34th St, 
New York, NY 
Languages Spoken:
English
Offers Telehealth

Orrin Devinsky is a Neurologist practicing medicine in New York, New York. Dr. Devinsky is rated as an Elite provider by MediFind in the treatment of Lennox-Gastaut Syndrome (LGS). He is also highly rated in 31 other conditions, according to our data. His clinical expertise encompasses Myoclonic Epilepsy, Dravet Syndrome, Seizures, Epilepsy, and Deep Brain Stimulation.

Elite in Lennox-Gastaut Syndrome (LGS)
Neurology | General Surgery
Elite in Lennox-Gastaut Syndrome (LGS)
Neurology | General Surgery
Referral may be required

AHN Neurology - Floor 2 At Hemlock Building

320 East North Avenue, 
Pittsburgh, PA 
Languages Spoken:
English
Offers Telehealth

James Valeriano is a Neurologist and a General Surgeon practicing medicine in Pittsburgh, Pennsylvania. Dr. Valeriano is rated as an Elite provider by MediFind in the treatment of Lennox-Gastaut Syndrome (LGS). He is also highly rated in 19 other conditions, according to our data. His clinical expertise encompasses Seizures, Lennox-Gastaut Syndrome (LGS), Memory Loss, and Generalized Tonic-Clonic Seizure. Dr. Valeriano is board certified in American Board Of Psychiatry And Neurology - Neurology.

 
 
 
 
Learn about our expert tiers
Learn More
Distinguished in Lennox-Gastaut Syndrome (LGS)
Distinguished in Lennox-Gastaut Syndrome (LGS)
Referral may be required

Northwell Health Physician Partners Neuroscience Institute At Great Neck

611 Northern Boulevard, Suite 150, 
Great Neck, NY 
Languages Spoken:
English, Hebrew, Spanish
Accepting New Patients
Offers Telehealth

Ruben Kuzniecky is a Neurologist practicing medicine in Great Neck, New York. Dr. Kuzniecky is rated as a Distinguished provider by MediFind in the treatment of Lennox-Gastaut Syndrome (LGS). He is also highly rated in 12 other conditions, according to our data. His clinical expertise encompasses Epilepsy, Seizures, Generalized Tonic-Clonic Seizure, and Partial Seizure. Dr. Kuzniecky is board certified in American Board Of Psychiatry/Neurology-Neurology. Dr. Kuzniecky is currently accepting new patients.

What are the latest Lennox-Gastaut Syndrome (LGS) Clinical Trials?
Multicenter, Randomized, Double-blind, Placebo-controlled Trial of Clemizole HCl as Adjunctive Therapy in Patients With Lennox-Gastaut Syndrome

Summary: This is a multicenter, Phase 3, randomized, double-blind, placebo-controlled study designed to evaluate the efficacy and safety of clemizole HCL (EPX-100) as adjunctive therapy in children and adult participants with Lennox-Gastaut syndrome (LGS).

Match to trials
Find the right clinical trials for you in under a minute
Get started
A Phase 1b, Multicenter, Open-Label, Single-arm Study to Evaluate the Efficacy and Safety of Cannabidiol Oral Solution (CBD-OS [GWP42003-P, JZP926]) in Participants Aged 12 to 75 Years for the Treatment of Focal-Onset Seizures

Summary: Cannabidiol oral solution (CBD-OS) is approved in the US for the treatment of seizures associated with Lennox-Gastaut syndrome (LGS), Dravet syndrome (DS), or Tuberous sclerosis complex (TSC) in patients 1 year of age and older. This study will assess the efficacy and safety of CBD-OS in participants aged 12 to 75 years for the treatment of focal-onset seizures (FOS).

Who are the sources who wrote this article ?

Published Date: May 03, 2023
Published By: National Institutes of Health